Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Filing date
Publication date
Priority claimed from JP11738572Aexternal-prioritypatent/JPS5727114B2/ja
Priority claimed from JP11911372Aexternal-prioritypatent/JPS5727115B2/ja
Priority claimed from JP12663672Aexternal-prioritypatent/JPS5535397B2/ja
Priority claimed from JP8785173Aexternal-prioritypatent/JPS5641635B2/ja
Priority claimed from JP8785573Aexternal-prioritypatent/JPS5643472B2/ja
Priority claimed from JP8785473Aexternal-prioritypatent/JPS5643471B2/ja
Application filed by Fujisawa Pharmaceutical Co LtdfiledCriticalFujisawa Pharmaceutical Co Ltd
Application grantedgrantedCritical
Publication of AU490070B2publicationCriticalpatent/AU490070B2/en
Publication of AU6277673ApublicationCriticalpatent/AU6277673A/en
16-phenoxy-11a,15a-dihydroxy-17,18,19,20-tetranor-5-cis-13-transprostadienoic acid and prostadienol derivatives and prostadienol derivatives and processes for their preparation